- Home
- ARWR vs NAC Comparison
ARWR vs NAC Comparison
Compare ARWR & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- NAC
- Stock Information
- Founded
- ARWR 2003
- NAC 1998
- Country
- ARWR United States
- NAC France
- Employees
- ARWR N/A
- NAC N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- NAC Investment Managers
- Sector
- ARWR Health Care
- NAC Finance
- Exchange
- ARWR Nasdaq
- NAC Nasdaq
- Market Cap
- ARWR 1.8B
- NAC 1.6B
- IPO Year
- ARWR 1993
- NAC N/A
- Fundamental
- Price
- ARWR $12.95
- NAC $11.02
- Analyst Decision
- ARWR Buy
- NAC
- Analyst Count
- ARWR 11
- NAC 0
- Target Price
- ARWR $41.44
- NAC N/A
- AVG Volume (30 Days)
- ARWR 1.7M
- NAC 307.3K
- Earning Date
- ARWR 05-12-2025
- NAC 01-01-0001
- Dividend Yield
- ARWR N/A
- NAC 4.33%
- EPS Growth
- ARWR N/A
- NAC N/A
- EPS
- ARWR N/A
- NAC N/A
- Revenue
- ARWR $2,500,000.00
- NAC N/A
- Revenue This Year
- ARWR $4,380.43
- NAC N/A
- Revenue Next Year
- ARWR $64.24
- NAC N/A
- P/E Ratio
- ARWR N/A
- NAC N/A
- Revenue Growth
- ARWR N/A
- NAC N/A
- 52 Week Low
- ARWR $9.57
- NAC $9.32
- 52 Week High
- ARWR $30.41
- NAC $11.21
- Technical
- Relative Strength Index (RSI)
- ARWR 53.31
- NAC 57.56
- Support Level
- ARWR $12.44
- NAC $10.78
- Resistance Level
- ARWR $14.97
- NAC $11.05
- Average True Range (ATR)
- ARWR 0.71
- NAC 0.09
- MACD
- ARWR 0.16
- NAC 0.05
- Stochastic Oscillator
- ARWR 61.36
- NAC 97.17
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.